Skip to main content
PMC home page
Gut logoLink to Gut
. 1986 May;27(5):581–586. doi: 10.1136/gut.27.5.581

Effect of two new antisecretory drugs on fluid and electrolyte transport in a patient with secretory diarrhoea.

C Edwards, P A Cann, N W Read, C D Holdsworth
PMCID: PMC1433491  PMID: 2870957

Abstract

The effect of oral lidamidine hydrochloride and subcutaneous long acting somatostatin analogue, SMS 201-995, on stool output and salt and water transport in the small intestine was investigated in a patient with gross secretory diarrhoea caused by a vasoactive intestinal polypeptide (VIP) secreting tumour in the liver. Transport in the jejunum and ileum were assessed by steady state perfusion techniques. Under basal conditions, the patient was absorbing fluid and electrolytes from the jejunum and ileum, but at rates that were abnormally low. Lidamidine had no effect on either intestinal transport or stool frequency and output. SMS 201-995 increased intestinal absorption in the jejunum and ileum, reduced plasma VIP concentrations, daily stool frequency and weight, and enabled the patient to resume a normal diet without oral or intravenous fluid and electrolyte supplements. After two months of treatment, medical control was becoming increasingly difficult and stool output had risen again to 2 litres per day. Surgical resection, fortunately, was possible and led to resolution of symptoms and normal plasma VIP concentrations.

Full text

PDF
581

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloom S. R., Christofides N. D., Delamarter J., Buell G., Kawashima E., Polak J. M. Diarrhoea in vipoma patients associated with cosecretion of a second active peptide (peptide histidine isoleucine) explained by single coding gene. Lancet. 1983 Nov 19;2(8360):1163–1165. doi: 10.1016/s0140-6736(83)91215-1. [DOI] [PubMed] [Google Scholar]
  2. Dharmsathaphorn K., Binder H. J., Dobbins J. W. Somatostatin stimulates sodium and chloride absorption in the rabbit ileum. Gastroenterology. 1980 Jun;78(6):1559–1565. [PubMed] [Google Scholar]
  3. Dharmsathaphorn K., Sherwin R. S., Dobbins J. W. Somatostatin inhibits fluid secretion in the rat jejunum. Gastroenterology. 1980 Jun;78(6):1554–1558. [PubMed] [Google Scholar]
  4. Durbin T., Rosenthal L., McArthur K., Anderson D., Dharmsathaphorn K. Clonidine and lidamidine (WHR-1142) stimulate sodium and chloride absorption in the rabbit intestine. Gastroenterology. 1982 Jun;82(6):1352–1358. [PubMed] [Google Scholar]
  5. Gullikson G. W., Dajani E. Z., Bianchi R. G. Inhibition of intestinal secretion in the dog: a new approach for the management of diarrheal states. J Pharmacol Exp Ther. 1981 Dec;219(3):591–597. [PubMed] [Google Scholar]
  6. Kayasseh L., Gyr K., Stalder G. A., Rittmann W. W., Girard J. Effect of somatostatin on exocrine pancreatic secretion stimulated by pancreozymin-secretin or by a test meal in the dog. Horm Res. 1978;9(3):176–184. doi: 10.1159/000178911. [DOI] [PubMed] [Google Scholar]
  7. Kraenzlin M. E., Ch'ng J. L., Wood S. M., Carr D. H., Bloom S. R. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases. Gastroenterology. 1985 Jan;88(1 Pt 1):185–187. doi: 10.1016/s0016-5085(85)80153-0. [DOI] [PubMed] [Google Scholar]
  8. Krejs G. J., Browne R., Raskin P. Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes. Gastroenterology. 1980 Jan;78(1):26–31. [PubMed] [Google Scholar]
  9. Maton P. N., O'Dorisio T. M., Howe B. A., McArthur K. E., Howard J. M., Cherner J. A., Malarkey T. B., Collen M. J., Gardner J. D., Jensen R. T. Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera. N Engl J Med. 1985 Jan 3;312(1):17–21. doi: 10.1056/NEJM198501033120104. [DOI] [PubMed] [Google Scholar]
  10. McArthur K. E., Anderson D. S., Durbin T. E., Orloff M. J., Dharmsathaphorn K. Clonidine and lidamidine to inhibit watery diarrhea in a patient with lung cancer. Ann Intern Med. 1982 Mar;96(3):323–325. doi: 10.7326/0003-4819-96-3-323. [DOI] [PubMed] [Google Scholar]
  11. Mir G. N., Alioto R. L., Sperow J. W., Eash J. R., Krebs J. B., Yelnosky J. In vivo antimotility and antidiarrheal activity of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent. Comparison with diphenoxylate and loperamide. Arzneimittelforschung. 1978;28(8A):1448–1454. [PubMed] [Google Scholar]
  12. Modigliani R., Rambaud J. C., Bernier J. J. The method of intraluminal perfusion of the human small intestine. I. Principle and technique. Digestion. 1973;9(2):176–192. doi: 10.1159/000197443. [DOI] [PubMed] [Google Scholar]
  13. Molla A. M., Gyr K., Bardhan P. K., Molla A. Effect of intravenous somatostatin on stool output in diarrhea due to Vibrio cholerae. Gastroenterology. 1984 Oct;87(4):845–847. [PubMed] [Google Scholar]
  14. Read N. W., Read M. G., Krejs G. J., Hendler R. S., Davis G., Fordtran J. S. A report of five patients with large-volume secretory diarrhea but no evidence of endocrine tumor or laxative abuse. Dig Dis Sci. 1982 Mar;27(3):193–201. doi: 10.1007/BF01296914. [DOI] [PubMed] [Google Scholar]
  15. Ruskoné A., René E., Chayvialle J. A., Bonin N., Pignal F., Kremer M., Bonfils S., Rambaud J. C. Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera. Dig Dis Sci. 1982 May;27(5):459–466. doi: 10.1007/BF01295657. [DOI] [PubMed] [Google Scholar]
  16. Williams N. S., Cooper J. C., Axon A. T., King R. F., Barker M. Use of a long acting somatostatin analogue in controlling life threatening ileostomy diarrhoea. Br Med J (Clin Res Ed) 1984 Oct 20;289(6451):1027–1028. doi: 10.1136/bmj.289.6451.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES